Group One Trading, L.P. Crinetics Pharmaceuticals, Inc. Transaction History

Group One Trading, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$25.62 - $37.07 $45,168 - $65,354	-1,763 Reduced 21.42%	6,466 $230,000
Q3 2023 Nov 09, 2023	BUY	$15.97 - $30.59 $131,417 - $251,725	8,229 New	8,229 $244,000
Q2 2022 Aug 11, 2022	SELL	$16.49 - $27.64 $120,673 - $202,269	-7,318 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$17.15 - $28.31 $30,166 - $49,797	1,759 Added 31.64%	7,318 $161,000
Q4 2021 Feb 11, 2022	BUY	$19.35 - $28.41 $107,566 - $157,931	5,559 New	5,559 $158,000

244

78.2M

268K

197K

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.73B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.